Original language | English |
---|---|
Pages (from-to) | 2530 |
Number of pages | 1 |
Journal | Annals of Oncology |
Volume | 22 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1 Jan 2011 |
Evaluating the risk-benefit ratio of adjuvant trastuzumab-based therapy for t1a,bN0M0 her2-positive breast carcinomas
M. J. Rodrigues, L. Albiges-sauvin, J. Wassermann, P. H. Cottu
Research output: Contribution to journal › Letter › peer-review
5
Citations
(Scopus)